Inactive

THIS IS A SOURCES SOUGHT ANNOUNCEMENT, A MARKET SURVEY FOR WRITTEN INFORMATION ONLY. THIS IS NOT A SOLICITATION ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT. NO RE... THIS IS A SOURCES SOUGHT ANNOUNCEMENT, A MARKET SURVEY FOR WRITTEN INFORMATION ONLY. THIS IS NOT A SOLICITATION ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT. NO REIMBURSEMENT WILL BE MADE FOR ANY COSTS ASSOCIATED WITH PROVIDING INFORMATION IN RESPONSE TO THIS ANNOUNCEMENT OR ANY FOLLOW-UP INFORMATION REQUESTS. NO TELEPHONE CALLS WILL BE ACCEPTED REQUESTING AN RFQ PACKAGE OR SOLICITATION. THERE IS NO RFQ PACKAGE OR SOLICITATION. IN ORDER TO PROTECT THE PROCUREMENT INTEGRITY OF ANY FUTURE PROCUREMENT, IF ANY, THAT MAY ARISE FROM THIS ANNOUNCEMENT, INFORMATION REGARDING THE TECHNICAL POINT OF CONTACT WILL NOT BE GIVEN AND NO APPOINTMENTS FOR PRESENTATIONS WILL BE MADE. The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS) is issuing this source sought announcement on behalf of the National Center for Toxicological Research (NCTR), Neurotoxicology, in order to determine if there are existing small business sources capable of providing the Long-Evans (LE) or Sprague-Dawley (SD) rats described herein. Other than small business concerns, especially vendors who may be able to offer domestic products, are also encouraged to submit a capability statement that provides company information, as well as information demonstrating that it can meet all of the minimum requirements included below, to include the country of manufacture of products offered. If your firm is considered a small business source under North American Industry Classification System (NAICS) Code 112990- All Other Animal Production; Small Business Size Standard is $2.75 million, and you believe that your firm would be able to provide the FDA with the supplies/services described below, please submit an email to Warren.Dutter@fda.hhs.gov. Background: The U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), Division of Neurotoxicology requires Long-Evans (LE) or Sprague-Dawley (SD) rats delivered on a schedule. The rats (Timed Pregnant) are needed to act as a gestational model and will need to arrive in shipments every 3-5 weeks during the duration of the research project E0782511. The rat is the most appropriate species as they display a broad spectrum of behavior, are capable of complex learning and memory tasks, and findings based on them are easily translatable to humans. The LE and SD rat strains are commonly used laboratory animal models and the NCTR laboratory has experience with both strains. These strains are good multipurpose models that breed well, are easy to handle, and are commonly used in safety and toxicity studies. Additional young female and male rats are needed to optimize study assays. Minimum Requirements for the Long-Evans (LE) or Sprague-Dawley (SD) Rats: All rats shall be outbred and of the Long Evans (LE) or Sprague-Dawley (SD) strain, but facility specific sub-strains of either strain are acceptable. All rats shall come from a housing room that has tested negative for the following pathogens for the last 18 months: Viruses: MHV; MVM(MMV); TMEV; EDIM; Sendai Virus; PVM; Norovirus; REO3; LCMV; Ectromelia virus; NS-1(generic Parvovirus); RPV; KRV; RTV (rat theilovirus) Bacteria: Helicobacter; Pneumocystis carinii; Mycoplasma pulmonis; C. kutcheri; P. multocida; Salmonella spp.; CAR Bacillus; Tyzzer’s Disease; B. bronchiseptica; K. oxytoca; P. pneumotropica; Pseudomonas aeruginosa Parasites: E. cuniculi; Helminths (Pinworms); Ectoparasites; Giardia (i.e., shall comply with the NCTR Rodent Opportunistic Pathogen Exclusion List) All rats shall be delivered on an agreed upon day of the week (e.g., Mondays or Tuesdays), but exceptions for federal holidays will be necessary. Within a given shipment of Timed Pregnant Dams an indicator of the rat’s Dam and Sire, Date of Birth, Date of Pairing, and Date Copulatory Plug Observed shall be provided. Shipments of young (non-mated) male and female rats may be composed of littermates, but a Date of Birth shall be provided. Warranty and Reports: Warranty Service Requirements: The Vendor shall guarantee that each shipment contains animals in good health. Shipments that contain injured, moribund, or dead animals shall be replaced at no cost. Records and Reports: The Vendor shall supply health reports from the colony of origin for each shipment of rats to ensure that the rats meet the requirements of the NCTR colony exclusion list. The Vendor shall provide birth dates for all animals within each shipment. Delivery Schedule: See Attachment A Place of Performance: FOB Point Destination. All items shall include shipping, handling and inside delivery to the destination identified herein. FDA - NCTR 3900 NCTR Rd Jefferson, Arkansas 72079 Period of Performance: 8/19/2025– 12/29/2026 The period of performance for this contract shall start with the date of first shipment, which is currently requested as 8/19/2025. There are 24 deliveries total, with the final delivery scheduled as 12/29/2026. Deliveries shall not be scheduled during Federal Holidays or Federal Closures as determined by Executive Orders or WWW.OPM.GOV. Responses to this Sources Sought shall unequivocally demonstrate that the respondent is regularly engaged in the sale of same or substantially similar product/service. Though the target audience is small business vendors or small businesses capable of supplying a U.S. service of a small business vendor or producer all interested parties may respond. At a minimum, responses shall include the following: Business name and bio, unique entity identification (UEI) number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, SDB, WOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address. Provide this same information again if responding to provide a service offered by another firm. Past Performance information for the manufacturer and/or sale of same or substantially similar product and service or similar brand instruments to include date of sale, description, dollar value, client name, client address, client contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include UEI number and size status) if not the respondent. Descriptive literature, brochures, marketing material, etc. detailing the nature of the product and service the responding firm is regularly engaged in manufacturing and/or selling. The offeror shall furnish sufficient technical information necessary for the Government to conclusively determine that the offered items/services meet the technical requirements identified above. If applicable, identification of Best in Class (BIC) contract information or other Government-wide or HHS-wide contracts that the equipment/service is available on. If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this potential requirement are also requested. If a large business, provide whether subcontracting opportunities exist for small business concerns. Standard commercial warranty and payment terms. Provide place of product manufacture or service performance and any other applicable information to enable review and analysis pertaining to the Buy American statute and requirements relating to Made in America in the event a nonavailability waiver request through the MIAO Digital Waiver Portal is needed. Informational pricing is desired. The Government is not responsible for locating or securing any information, not identified in the response. Interested Contractors must respond with capability statements which are due by email to the point of contact listed below on or before July 7, 2025, by 1:00 PM Central Time at the Food and Drug Administration, Field Operations Branch, FDA|OO|OFBA|OAGS|DAP, Attn: Warren Dutter, email warren.dutter@fda.hhs.gov. Reference: FDA-SSN-130252. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre?solicitation synopsis and solicitation may be published in sam.gov. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality and Proprietary Information: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non?proprietary technical information in any resultant solicitation(s). Additional Notes: If the stated requirements appear restrictive, please submit comments detailing the concern. Though this is not a request for quote, informational pricing for the service would be helpful.